CPNG INVESTOR ALERT: Coupang, Inc. Investors with Substantial Losses Have Opportunity to Lead the Coupang Class Action Lawsuit
CoupangCoupang(US:CPNG) Prnewswire·2026-01-20 14:21

Core Viewpoint - Hagens Berman is notifying investors about a pending securities class action against Coupang, Inc. regarding alleged misrepresentation of cybersecurity protocols and a significant data breach affecting customer information [1][2]. Group 1: Legal Proceedings - The lead plaintiff deadline for the class action lawsuit is set for February 17, 2026 [3]. - The expanded class period for affected investors is from May 7, 2025, to December 16, 2025 [3]. - The key allegation involves delayed disclosure of a cybersecurity breach detected on November 18, 2025 [3][4]. Group 2: Allegations and Breach Details - The lawsuit claims that Coupang misled investors by assuring them of adequate cybersecurity measures while failing to disclose a breach that allowed unauthorized access to sensitive customer data [2][4]. - On November 29, 2025, Coupang revealed that its internal systems were compromised, affecting approximately 33.7 million customer accounts in Korea [7]. - The breach is believed to have started on June 24, 2025, via overseas servers [7]. Group 3: Executive Changes and Regulatory Actions - Coupang's CEO, Park Dae-joon, resigned on December 10, 2025, in connection with the data leak incident, and Harold Rogers was appointed as interim CEO [7]. - On December 16, 2025, Coupang acknowledged awareness of the cybersecurity incident on November 18, 2025, prior to public disclosure [7]. - Korean regulators have initiated investigations into the breach, and Coupang is cooperating fully [7]. Group 4: Compensation and Future Actions - Following the breach, Coupang announced a compensation plan of 1.685 trillion won (over $1 billion) to restore customer trust [7]. - Reports suggest that the breach may have involved authentication keys that were valid for an extended period, raising questions about the adequacy of Coupang's cybersecurity protocols [8].